Episodes
-
The latest episode of the DDW Highlights podcast is now available. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
It’s been a big week for cell and gene therapies (CGTs) as the first in vivo BCMA CAR-T candidate reaches the clinic and a new discovery could lead to a gene therapy that reverses a significant cause of stillbirth and premature delivery.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This episode of the DDW narrated podcast series is titled “New ways to treat cancer”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “3D Genomics and targeted cancer therapies”, “Democratising proteomics for cancer and beyond”, and Meet the Researcher: John Maher”
In the first article, Anthony Schmitt, PhD, Senior Vice President, Science at Arima Genomics, discusses the applications of 3D genomics in cancer research.
In the second article, DDW Editor Reece Armstrong speaks to Nautilus Co-Founder and Chief Scientist Parag Mallick, about the company’s recent collaboration which aims to uncover the proteins that could be behind a rare and fatal childhood cancer.
In the third article, John Maher, Leucid Bio, told me about his work and offers valuable advice to others in this field.
-
Missing episodes?
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week’s leading news stories all shine a light on innovation within drug discovery, including a potential ‘best-in-industry’ weight loss drug, a gold-based compound that shrinks tumours by 82%, and a second-generation CAR-T therapy.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This episode of the DDW narrated podcast series is titled “The far-reaching impact of drug discovery technology”, which covers three articles written for Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “Accelerating time to market through digitalisation”, “Why digital biomarkers will power tomorrow’s Alzheimer’s therapies”, and “The path to improved safety of gene-based products”.
In the first article, Sascha Fischer Business Development Manager for Automation at Genedata looks at three critical digitalisation components that enable end-to-end lab automation, improve the return on investment (ROI) on instrumentation investments and streamline time-to-market.
In the second article, Rivka Kreitman, CIO of NeuraLight explores the landscape of therapies for Alzheimer’s and explains why digital biomarkers are key to combatting the disease.
In the third article, Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week’s leading news stories all feature early-stage clinical trials, including a short interfering RNA for cardiovascular disease, a new type of drug for type 2 diabetes, a gene therapy for Duchenne muscular dystrophy, a T cell therapy for hepatitis B, and a monoclonal antibody to prevent respiratory syncytial virus.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘Avoiding detection – the cancer cells evading the body’s natural defence’.
In the first article, DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country.
In the second article, DDW Editor Reece Armstrong explores recent research looking into why cancer cells are so effective at avoiding the body’s immune system.
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week’s most exciting news stories all represent innovative solutions to the treatment of disease, proving that ‘thinking outside the box’ can by the key to success in drug discovery.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
With the Society for Immunotherapy of Cancer (SITC) 2024 taking place in Houston recently, there have been a number of recent announcements regarding the clinical advancement of immunocytokines, METTL3 inhibitors, cancer vaccines, CAR-T therapies and immune checkpoint inhibitors for the treatment of cancer.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week DDW has reported on significant investment in the development of treatments for neurodegenerative diseases, but also gene therapies for CNS disorders and radioligand-based therapies for cancer.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively, a new indication for Fasenra was approved in the EU, researchers found an antibody platform could overcome the challenges of treating mutating viruses, and monoclonal antibodies showed promise in lung cancer and immunoglobulin A nephropathy.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled "How to streamline regulatory approval", which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The three key stages to a successful specialty drug launch.
In the first article, Ken Forman, Senior Director of Product Strategy, IDBS explains how robust digital workflows can reduce errors and time to compile data leading to greater transparency, faster reporting and help biopharmaceutical companies reach regulatory submission faster.
In the second article, Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on the agenda, so the news round-up this week focuses on investment in drug discovery, by private investors, governments and charities.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael Wyand, where we talk about Oxeia’s work; the unmet critical need for concussion drug therapies; the challenges facing them, including in clinical trials and investment; the potential market for concussion drugs, and more.
You can now, and find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
As we are halfway through Breast Cancer Awareness Month, our news highlights this week focus on studies that could advance the treatment of cancer in the future, including a new understanding of cancer drug resistance, and novel therapeutics like radioimmunotherapy, RBM39 degraders and peptide-drug conjugates.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Recently, the Society for Neuroscience's annual meeting took place, so the headlines have been dominated by the latest discoveries related to the brain and the central nervous system, including significant findings related to GLP-1 agonists and an advanced theory of bipolar disorder.
If these are of interest, don’t forget to register for DDW’s Neuroscience Showcase on 24 October.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available.
The publication of DDW’s latest eBook on immunotherapy has coincided with some interesting developments in this therapy area, particularly monoclonal antibodies, including two new regulatory approvals.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week we have seen a number of developments related to cell therapies, particularly CAR-T cell therapies, beyond their traditional use in haematological malignancies.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Immunotherapy offers survival extension for brain tumour patients and The evolution of assays for immuno-oncology research.
The first article looks into why data from a Phase III clinical trial offers promise for patients with a deadly form of brain cancer.
The second article shares insight from Dr Shailendra Singh, Founder and CEO of Cellomatics Biosciences.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week, DDW has opened registrations for its webinar ‘The latest advancements driving neuroscience drug discovery research’, so our news highlights focus on developments in neuroscience, including a novel drug that has been shown to reduce neuronal death, and a potential disease-modifying treatment for dementia.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this episode, Megan Thomas is in conversation with Dr Friso Postma, Vice President of AI Drug Discovery at BioXcel Therapeutics.
Thanks to BioXcel's AI platform, the company was able to repurpose previous drugs to obtain FDA approval for its acute treatment for agitation associated with schizophrenia and bipolar disorder, IGALMI, in April 2022, which was the first drug development success that involved the actual use of AI.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
- Show more
